Evaluation of ORTHOPUS Partner Arm in People With Disabilities Needing for Robotic Assistance to Compensate for Upper Limb Deficiency
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Feb 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to evaluate how well a robotic assistance device, called ORTHOPUS, can help people with upper limb disabilities. The goal is to see if this device can improve daily activities for those who have limited use of their arms. The study will involve multiple centers and will be open to all genders, focusing on participants aged 21 and older who have lost mobility in their upper limbs.
To join the trial, participants must have very limited movement in their arms, as measured by a specific scale, and be able to show some effective movements with the device. It's important for participants to be able to understand the trial and provide consent, or have a guardian do so if they are minors. Additionally, a family member must be present during the setup visit, and someone will need to record videos of how the device is used in everyday life. Those with certain cognitive issues, recent arm fractures, or who are already in another clinical study won't be able to participate. This is an exciting opportunity to help researchers learn more about improving mobility for people with disabilities!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have a loss of mobility in the upper limb (UL).
- • Have minimal functional capacities in the upper limb, defined by a score between 1 and 4 on the Lovett scale for all muscle groups of the arm, except for the hand and wrist.
- • Demonstrate effective distal motor skills in the upper limb to be fitted.
- • Be an informed patient who has provided signed consent, or in the case of minors, have given assent along with the signed consent of legal guardians.
- • A relative must be available for the installation visit, and either the patient or the relative must have the necessary equipment to record videos in ecological conditions (smartphone or tablet).)
- Exclusion Criteria:
- • Patients with cognitive or behavioral dysfunctions that may compromise adherence to instructions and procedures required for the trial (at the discretion of the investigator clinician).
- • Patients already enrolled in an interventional clinical trial.
- • History of fractures in the upper limb to be fitted within the six months preceding the inclusion visit in the trial.
- • Any conditions or injuries that may interfere with functional assessments.
- • Patients under legal guardianship or curatorship.
- • Lack of health insurance coverage.
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Thibaud LANSAMAN, MD
Principal Investigator
SMR DEPARTMENT, Raymon Pincaré Hospital - APHP
Samuel POUPLIN, PhD
Study Director
PFNT DEPARTMENT, Raymon Pincaré Hospital - APHP
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported